Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 271, Issue 3 15-3, 1996, Pages

  Uchiba, Mitsuhiro ^a   Okajima, Kenji ^a   Murakami, Kazunori ^a   Johno, Masayoshi ^a   Okabe, Hiroaki ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

activated protein C; leukocytes; recombinant human soluble thrombomodulin

Indexed keywords

ACTIVATED PROTEIN C; ENDOTOXIN; THROMBOMODULIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFLAMMATORY INFILTRATE; LEUKOCYTE ACTIVATION; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0029819270     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.271.3.l470     Document Type: Article

References (26)

1. Aoki, Y., R. Takei, M. Mohri, Y. Gonda, K. Gomi, T. Sugihara, T. Kiyota, T. Ishida, and I. Maruyama. Antithrombotic effect of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats. Am. J. Hematol. 47: 162-166, 1994.
2. Bachonfen, M., and E. F. Weibel. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3: 35-56, 1982.
3. Bajaj, S. P., S. I. Rapaport, and C. A. Prodanos. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep. Biochem. 11: 397-412, 1981.
4. Bevilacqua, M. P., J. S. Pober, D. L. Mendrick, R. S. Cotan, and M. A. Gimbrone. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84: 9238-9242, 1987.
5. Bone, R. C., P. B. Francis, and A. K. Pierce. Intravascular coagulation associated with the adult respiratory distress syndrome. Am J. Med. 61: 585-589, 1976.
6. 1 Study Group. An early test of survival in patients with the adult respiratory distress syndrome. Chest 96: 849-851, 1989.
7. Bone, R. C., R. Ursprung, G. Slotman, R. Maunder, H. Silverman, T. M. Hyers, and M. D. Kerstein. Adult respiratory distress syndrome. Chest 101: 320-326, 1992.
8. Chang, S. W. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor. J. Lab. Clin. Med. 123: 65-72, 1994.
9. Chang, S. W., N. Ohara, G. Kuo, and N. F. Voelkel. Tumor necrosis factor-α induced lung injury is not mediated by platelet-activating factor. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L232-L239, 1989.
10. Clauss, A. Rapid physiological coagulation method for the determination of fibrinogen. Acta Haematol. Basel 17: 237-246, 1957.
11. Comp, P. C. Clinical implications of the protein C/protein S system. Ann. NY Acad. Sci. 509: 149-155, 1987.
12. Cooper, J. A., S. J. Solano, R. Bizios, J. E. Kaplan, and A. B. Malik. Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation. J. Appl. Physiol. 57: 826-832, 1984.
13. Dentener, M. A., V. Bazil, E. J. U. von Asmuth, M. Ceska, and W. A. Buurmaa. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J. Immunol. 150: 2885-2891, 1993.
14. Esmon, C. T., F. B. Taylor, Jr., and T. R. Snow. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb. Haemostasis 66: 160-165, 1991.
15. Esmon, N. L., W. G. Owen, and C. T. Esmon. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 257: 859-864, 1982.
16. Fouw, N. J., Y. E. Jong, F. Haverkate, and R. M. Bertina. Activated protein C increase fibrin clot lysis by neutralization of plasminogen activator inhibitor: no evidence for a cofactor role of protein S. Thromb. Haemostasis 60: 328-333, 1988.
17. Garcia, J. G. N., A. Siflinger-Birnboim, R. Bizios, P. J. Del Vecchio, J. W. Fenton II, and A. B. Malik. Thrombin-induced increase in albumin permeability across the endothelium. J. Cell. Physiol. 128: 96-104, 1986.
18. Gomi, K., M. Zushi, G. Honda, S. Kawahara, O. Matsuzaki, T. Kanabayashi, S. Yamamoto, I. Maruyama, and K. Suzuki. Antithrombotic effect of recombinant human soluble thrombomodulin on thrombin-induced thromboembolism in mice. Blood 75: 1396-1399, 1990.
19. Gonda, Y., S. Hirata, K. Saitoh, Y. Aoki, M. Mohri, K. Gomi, T. Sugihara, T. Kiyota, S. Yamamoto, T. Ishida, and I. Maruyama. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb. Res. 71: 325-335, 1993.
20. Grey, S., H. Hau, H. H. Salem, and W. W. Hancock. Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-γ, or PMA: modulation of effects on CD11b and CD14 but not CD25 or CD54 induction. Transplant. Proc. 25: 2913-2914, 1993.
21. Grinnell, B. W., R. B. Hermann, and S. B. Yan. Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 4: 221-225, 1994.
22. Hasegawa, N., A. W. Husari, W. T. Hart, T. G. Kandra, and T. A. Raffin. Role of the coagulation system in ARDS. Chest 105: 268-277, 1994
23. Heflin, A. J., and K. L. Brigham. Prevention by granulocyte depletion of increased pulmonary vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68: 1253-1260, 1981.
24. Kaplan, J. E., and A. B. Malik. Thrombin-induced intravascular coagulation: role in vascular injury. Semin. Thromb. Hemostasis 13: 398-415, 1987.
25. Minnear, F. L., D. Martin, L. Hill, A. E. Taylor, and A. B. Malik. Lung morphological and permeability changes induced by intravascular coagulation in dogs. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H634-H644, 1987.
26. Morita, T., and C. M. Jackson. Localization of the structural difference between bovine blood coagulation factor X1 and X2 to tyrosine 18 in the activation peptide. J. Biol. Chem. 261: 4008-4014, 1986.